annual CFO:
$18.81B-$4.03B(-17.66%)Summary
- As of today (May 29, 2025), ABBV annual cash flow from operations is $18.81 billion, with the most recent change of -$4.03 billion (-17.66%) on December 31, 2024.
- During the last 3 years, ABBV annual CFO has fallen by -$3.97 billion (-17.43%).
- ABBV annual CFO is now -24.60% below its all-time high of $24.94 billion, reached on December 31, 2022.
Performance
ABBV Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$1.64B-$5.41B(-76.80%)Summary
- As of today (May 29, 2025), ABBV quarterly cash flow from operations is $1.64 billion, with the most recent change of -$5.41 billion (-76.80%) on March 1, 2025.
- Over the past year, ABBV quarterly CFO has dropped by -$2.40 billion (-59.53%).
- ABBV quarterly CFO is now -79.40% below its all-time high of $7.93 billion, reached on September 30, 2021.
Performance
ABBV quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$16.40B-$2.40B(-12.79%)Summary
- As of today (May 29, 2025), ABBV TTM cash flow from operations is $16.40 billion, with the most recent change of -$2.40 billion (-12.79%) on March 1, 2025.
- Over the past year, ABBV TTM CFO has dropped by -$6.29 billion (-27.70%).
- ABBV TTM CFO is now -35.79% below its all-time high of $25.54 billion, reached on June 30, 2023.
Performance
ABBV TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ABBV Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.7% | -59.5% | -27.7% |
| 3 y3 years | -17.4% | -66.7% | -28.1% |
| 5 y5 years | +41.1% | -57.1% | +16.1% |
ABBV Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.6% | at low | -78.5% | at low | -35.8% | at low |
| 5 y | 5-year | -24.6% | +41.1% | -79.4% | at low | -35.8% | +16.1% |
| alltime | all time | -24.6% | +429.9% | -79.4% | +382.9% | -35.8% | +1179.6% |
ABBV Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.64B(-76.8%) | $16.40B(-12.8%) |
| Dec 2024 | $18.81B(-17.7%) | $7.05B(+29.4%) | $18.81B(+13.9%) |
| Sep 2024 | - | $5.45B(+139.9%) | $16.51B(-11.4%) |
| Jun 2024 | - | $2.27B(-43.8%) | $18.64B(-17.8%) |
| Mar 2024 | - | $4.04B(-15.0%) | $22.69B(-0.7%) |
| Dec 2023 | $22.84B(-8.4%) | $4.75B(-37.2%) | $22.84B(-10.5%) |
| Sep 2023 | - | $7.57B(+19.9%) | $25.51B(-0.1%) |
| Jun 2023 | - | $6.32B(+50.7%) | $25.54B(+5.4%) |
| Mar 2023 | - | $4.19B(-43.6%) | $24.23B(-2.9%) |
| Dec 2022 | $24.94B(+9.5%) | $7.43B(-2.3%) | $24.94B(+10.4%) |
| Sep 2022 | - | $7.60B(+51.9%) | $22.59B(-1.5%) |
| Jun 2022 | - | $5.00B(+2.0%) | $22.92B(+0.5%) |
| Mar 2022 | - | $4.91B(-3.3%) | $22.81B(+0.1%) |
| Dec 2021 | $22.78B(+29.5%) | $5.08B(-36.0%) | $22.78B(+1.0%) |
| Sep 2021 | - | $7.93B(+62.3%) | $22.56B(+10.3%) |
| Jun 2021 | - | $4.89B(+0.3%) | $20.45B(+9.7%) |
| Mar 2021 | - | $4.88B(+0.5%) | $18.65B(+6.0%) |
| Dec 2020 | $17.59B(+32.0%) | $4.85B(-16.7%) | $17.59B(+9.9%) |
| Sep 2020 | - | $5.83B(+88.7%) | $16.01B(+8.7%) |
| Jun 2020 | - | $3.09B(-19.0%) | $14.73B(+4.3%) |
| Mar 2020 | - | $3.81B(+16.5%) | $14.12B(+6.0%) |
| Dec 2019 | $13.32B(-0.8%) | $3.27B(-28.1%) | $13.32B(-0.9%) |
| Sep 2019 | - | $4.55B(+83.9%) | $13.44B(+0.2%) |
| Jun 2019 | - | $2.48B(-17.9%) | $13.41B(-2.8%) |
| Mar 2019 | - | $3.02B(-11.1%) | $13.80B(+2.8%) |
| Dec 2018 | $13.43B(+34.8%) | $3.39B(-25.0%) | $13.43B(+6.4%) |
| Sep 2018 | - | $4.52B(+57.9%) | $12.62B(+11.0%) |
| Jun 2018 | - | $2.87B(+8.4%) | $11.37B(+8.2%) |
| Mar 2018 | - | $2.65B(+2.4%) | $10.50B(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $9.96B(+41.5%) | $2.58B(-21.0%) | $9.96B(+11.7%) |
| Sep 2017 | - | $3.27B(+63.3%) | $8.92B(+25.6%) |
| Jun 2017 | - | $2.00B(-4.7%) | $7.10B(+1.2%) |
| Mar 2017 | - | $2.10B(+36.4%) | $7.01B(-0.4%) |
| Dec 2016 | $7.04B(-6.6%) | $1.54B(+6.0%) | $7.04B(-5.7%) |
| Sep 2016 | - | $1.45B(-24.2%) | $7.46B(-8.6%) |
| Jun 2016 | - | $1.92B(-9.9%) | $8.16B(+1.1%) |
| Mar 2016 | - | $2.13B(+8.4%) | $8.08B(+7.2%) |
| Dec 2015 | $7.54B(+112.3%) | $1.96B(-8.9%) | $7.54B(+50.9%) |
| Sep 2015 | - | $2.15B(+17.6%) | $4.99B(+8.0%) |
| Jun 2015 | - | $1.83B(+15.6%) | $4.63B(+2.5%) |
| Mar 2015 | - | $1.58B(-374.2%) | $4.51B(+27.1%) |
| Dec 2014 | $3.55B(-43.4%) | -$578.00M(-132.4%) | $3.55B(-33.9%) |
| Sep 2014 | - | $1.79B(+4.0%) | $5.37B(-0.2%) |
| Jun 2014 | - | $1.72B(+175.2%) | $5.38B(-5.6%) |
| Mar 2014 | - | $624.00M(-49.9%) | $5.70B(-9.0%) |
| Dec 2013 | $6.27B(-1.2%) | $1.25B(-30.8%) | $6.27B(+5.1%) |
| Sep 2013 | - | $1.80B(-11.7%) | $5.96B(-7.0%) |
| Jun 2013 | - | $2.04B(+71.6%) | $6.41B(+8.0%) |
| Mar 2013 | - | $1.19B(+26.1%) | $5.94B(-6.4%) |
| Dec 2012 | $6.34B(+1.6%) | $941.00M(-58.2%) | $6.34B(-1.7%) |
| Sep 2012 | - | $2.25B(+44.1%) | $6.45B(+8.0%) |
| Jun 2012 | - | $1.56B(-2.1%) | $5.97B(-8.9%) |
| Mar 2012 | - | $1.59B(+52.0%) | $6.56B(+5.0%) |
| Dec 2011 | $6.25B(+25.5%) | $1.05B(-40.7%) | $6.25B(+20.2%) |
| Sep 2011 | - | $1.77B(-17.6%) | $5.20B(+51.6%) |
| Jun 2011 | - | $2.15B(+67.5%) | $3.43B(+167.5%) |
| Mar 2011 | - | $1.28B | $1.28B |
| Dec 2010 | $4.98B(-7.3%) | - | - |
| Dec 2009 | $5.37B | - | - |
FAQ
- What is AbbVie annual cash flow from operations?
- What is the all time high annual CFO for AbbVie?
- What is AbbVie annual CFO year-on-year change?
- What is AbbVie quarterly cash flow from operations?
- What is the all time high quarterly CFO for AbbVie?
- What is AbbVie quarterly CFO year-on-year change?
- What is AbbVie TTM cash flow from operations?
- What is the all time high TTM CFO for AbbVie?
- What is AbbVie TTM CFO year-on-year change?
What is AbbVie annual cash flow from operations?
The current annual CFO of ABBV is $18.81B
What is the all time high annual CFO for AbbVie?
AbbVie all-time high annual cash flow from operations is $24.94B
What is AbbVie annual CFO year-on-year change?
Over the past year, ABBV annual cash flow from operations has changed by -$4.03B (-17.66%)
What is AbbVie quarterly cash flow from operations?
The current quarterly CFO of ABBV is $1.64B
What is the all time high quarterly CFO for AbbVie?
AbbVie all-time high quarterly cash flow from operations is $7.93B
What is AbbVie quarterly CFO year-on-year change?
Over the past year, ABBV quarterly cash flow from operations has changed by -$2.40B (-59.53%)
What is AbbVie TTM cash flow from operations?
The current TTM CFO of ABBV is $16.40B
What is the all time high TTM CFO for AbbVie?
AbbVie all-time high TTM cash flow from operations is $25.54B
What is AbbVie TTM CFO year-on-year change?
Over the past year, ABBV TTM cash flow from operations has changed by -$6.29B (-27.70%)